CBD Clinical Trial - Effects of Cannabidiol (CBD) on the Brain

Status Active, not recruiting

Clinical Trial Summary

Cannabidiol (CBD) is a phytocannabinoid that is one of 113 identified cannabinoids in the cannabis plant. It is derived from the hemp plant, and may treat conditions like pain, insomnia, and anxiety. CBD is a critical component of medical marijuana and does not cause the "high" typically associated with cannabis. According to the World Health Organization, CBD has shown no evidence of abuse or dependence potential. However, to the investigator's knowledge, there have not been many acute clinical studies to characterize the effects of CBD in the brain. Despite the rapid influx in CBD readily available to the public, very little is known about such effects. Some studies have shown alterations in resting state connectivity, while others have described changes in specific regions of the brain, or in networks associated with various cognitive functions. For example, CBD has been shown to increase fronto-striatal connectivity and reduce mediotemporal-prefrontal connectivity, suggesting that CBD may affect brain regions involved in salience processing. Unfortunately, few studies have examined CBD in isolation. Additionally, several studies have suggested that CBD may have a neuroprotective effect when it comes to individuals at high risk for psychiatric conditions. In this study, the investigators propose an acute administration, double-blind, placebo-controlled study in which 100% THC-free CBD will be compared to placebo (https://foliumbiosciences.com/). To the investigator's knowledge, the acute effects of this specific product have not been tested. Specifically, the investigators will examine: 1) the neurometabolic and neurophysiological effects of CBD compared to placebo and 2) the behavioral effects of CBD on measures of working memory and response inhibition. Participants will be recruited to take encapsulated, THC-free CBD provided by Folium Biosciences, in which they will have a pre- and post-ingestion scan. Each participant will have a 72-hour washout period after which they will be asked to come back for a placebo scan (however, the order will be counterbalanced so that equal numbers of participants will receive placebo/supplement and supplement/placebo). Individuals will be randomized into the supplementation group, as well as the order.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04831294
Study type	Interventional
Source	Auburn University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	July 15, 2021
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05534490` - Surgery and Functionality in Older Adults	N/A
Completed	`NCT04176822` - Designing Animated Movie for Preoperative Period	N/A
Completed	`NCT04127097` - The Effect of Watching Cartoons During Treatment on Children's Anxiety and Fear Levels	N/A
Recruiting	`NCT04039243` - Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study	N/A
Completed	`NCT03966391` - Effectiveness of CARD for Improving School-Based Immunizations	N/A
Completed	`NCT05955755` - The Effect of Butterfly Vacuum Blood Collection Set and Standard Vacutanier Needle on the Level of Pain and Fear	N/A
Completed	`NCT05191407` - Fear and Anxiety Level in Dental Patients During the COVID-19 Pandemic
Terminated	`NCT03966300` - Improving the School Vaccination Experience: What CARDs Are You Going to Play?	N/A
Completed	`NCT06112600` - The Impact of Virtual Reality and Kaleidoscope in Children During Vaccination	N/A
Completed	`NCT06012877` - Evaluation of the "Health Friendly" Program to Reduce Children's Fear of the Healthcare Environment.	N/A
Completed	`NCT05789810` - Manual Pressure and ShotBlocker to Reduce Needle-Related Pain and Fear	N/A
Not yet recruiting	`NCT05494684` - Effectiveness of Multisensoral Nature-based Intervention in Hospitalized Children During Venous Blood Sampling	N/A
Completed	`NCT04577612` - A Randomized Controlled Test of the Effects of CHI-554 on Fear.	Phase 2
Completed	`NCT04040036` - Effects of Virtual Reality on Pain, Fear and Anxiety During Blood Draw in Children Aged 5-12 Years Old	N/A
Active, not recruiting	`NCT03993509` - Effect of rTMS on Anxiety	N/A
Completed	`NCT04259463` - The Influence of Sedation and General Anesthesia to Patients' Psycho-emotional State Undergoing Wisdom Teeth Extraction
Completed	`NCT01398007` - Use of the Camouflage Syringe to Reduce Dental Anxiety and Fear in Children	Phase 2
Completed	`NCT05161416` - The Effects of Cartoon Watching and Bubble Blowing as Distraction Methods During Venipuncture on Pain, Anxiety, and Fear in Children Aged 6-8 Years	N/A
Completed	`NCT06090175` - The Effect of Using Projector Kaleidoscope and Matching Card on Children's Fear and Physiological Parameters	N/A
Recruiting	`NCT05543876` - The Effect of Video Watching With Virtual Reality Glasses on Pain and Fear of Children	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Cannabidiol (CBD) on the Brain — CBD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms